Variant report
Variant | nsv947496 |
---|---|
Chromosome Location | chr1:91918272-91938103 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565519838 | chr1:91918303-91918304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576970360 | chr1:91918331-91918332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541128780 | chr1:91918344-91918345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373952507 | chr1:91918466-91918467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201011228 | chr1:91918481-91918482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61659246 | chr1:91918506-91918507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570013669 | chr1:91918515-91918516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559056954 | chr1:91918525-91918526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369574276 | chr1:91918618-91918619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs397864003 | chr1:91918626-91918627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529706618 | chr1:91918674-91918675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541491352 | chr1:91918682-91918683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552267164 | chr1:91918696-91918697 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563598183 | chr1:91918745-91918746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566098861 | chr1:91918766-91918767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530757714 | chr1:91918781-91918782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79218631 | chr1:91918831-91918832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552048272 | chr1:91918873-91918874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535031259 | chr1:91918875-91918876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570317642 | chr1:91918878-91918879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565326839 | chr1:91918955-91918956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs207460292 | chr1:91918975-91918976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79452810 | chr1:91919051-91919052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12060889 | chr1:91919058-91919059 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs186402886 | chr1:91919065-91919066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567920351 | chr1:91919136-91919137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7542806 | chr1:91919225-91919226 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs535368127 | chr1:91919276-91919277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570353993 | chr1:91919290-91919291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7535665 | chr1:91919292-91919293 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs559143052 | chr1:91919321-91919322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577532848 | chr1:91919322-91919323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149565767 | chr1:91919337-91919338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553012522 | chr1:91919355-91919356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7526693 | chr1:91919358-91919359 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs72952982 | chr1:91919384-91919385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs516462 | chr1:91919413-91919414 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs145024818 | chr1:91919434-91919435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190028826 | chr1:91919439-91919440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs7526795 | chr1:91919440-91919441 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs13373992 | chr1:91919443-91919444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528255625 | chr1:91919458-91919459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7543080 | chr1:91919517-91919518 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs566160375 | chr1:91919520-91919521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371082085 | chr1:91919527-91919528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7540260 | chr1:91919533-91919534 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs80159576 | chr1:91919545-91919546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79585584 | chr1:91919546-91919547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142073025 | chr1:91919553-91919554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7526972 | chr1:91919578-91919579 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 16397240 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 20967226 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:91915600-91920000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr1:91916000-91919000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr1:91916000-91919400 | Weak transcription | Fetal Stomach | stomach |
4 | chr1:91916000-91919600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr1:91916400-91920800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:91918200-91919200 | Weak transcription | Fetal Kidney | kidney |
7 | chr1:91918800-91919000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr1:91919000-91921600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr1:91919000-91921600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
10 | chr1:91919200-91920200 | Enhancers | Fetal Kidney | kidney |
11 | chr1:91919400-91921200 | Enhancers | Fetal Stomach | stomach |
12 | chr1:91919600-91920200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr1:91920200-91920400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
14 | chr1:91920200-91921400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr1:91920200-91921600 | Weak transcription | Fetal Kidney | kidney |
16 | chr1:91921400-91921600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr1:91921600-91922000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr1:91921600-91923200 | Active TSS | Fetal Kidney | kidney |
19 | chr1:91922000-91922600 | Active TSS | Fetal Adrenal Gland | Adrenal Gland |
20 | chr1:91922000-91923400 | Enhancers | Fetal Intestine Large | intestine |
21 | chr1:91922200-91924200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr1:91923000-91923200 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
23 | chr1:91923400-91923600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
24 | chr1:91923400-91924400 | Weak transcription | Fetal Intestine Large | intestine |
25 | chr1:91924600-91924800 | Enhancers | Fetal Intestine Large | intestine |
26 | chr1:91931000-91933200 | Enhancers | Placenta | Placenta |